Infectious Diseases: Leading Suppliers Strategic Profiles

June 2016 | 155 pages | ID: IB3DB537B22EN
Venture Planning Group

Abstracts

This 155-page report provides detailed analyses of current and emerging technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scattering, chromatography and several others. The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 155 pages

Contents

Current and Emerging Technologies
Molecular Diagnostics
    a. Technology Overview
    b. Amplification Methods
  POLYMERASE CHAIN REACTION
Temperature Cyclers
PCR Variations
  IMMUNOPCR
  QCPCR
  DAPPCR
  LIGASE CHAIN REACTION
  BRANCHED DNA
  QBETA REPLICASE
  NUCLEICACID SEQUENCEBASED
  STRAND DISPLACEMENT ACTIVATION
Monoclonal Antibodies
Immunoassays
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
  OVERVIEW
  ELISA
  DOT IMMUNOBINDING ASSAYS
  CAPILLARY IMMUNOASSAYS
  PARTICLEMEMBRANE CAPTURE IMMUNOASSAYS
  ENZYME AMPLIFICATION
    c. Fluorescent Immunoassays
  FLUORESCENCE POLARIZATION
  TIMERESOLVED PULSE FLUORESCENCE
    d. Luminescence
  CHEMILUMINESCENCE
  BIOLUMINESCENCE
    e. Latex Agglutination
    f. Immunoprecipitation
Differential Light Scattering

IT

Artificial Intelligence
Liposomes
Flow Cytometry
Chromatography

MRI

Gel Microdroplets
Other

COMPETITIVE PROFILES

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/GenProbe
ID Biomedical*6.
Kreatech/HLFD
Lonza
OrthoClinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac3
Wako